Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer

Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer Molecular Therapy 24, 53 (January 2016). doi:10.1038/mt.2015.134 Authors: Chengwen Li, Shuqing Wu, Blake Albright, Matthew Hirsch, Wuping Li, Yu-Shan Tseng, Mavis Agbandje-McKenna, Scott McPhee, Aravind Asokan & R Jude Samulski

http://feeds.nature.com/~r/mt/rss/current/~3/9802ZGMXsCU/mt.2015.134

Source: Molecular Therapy - February 8, 2016 Category: Genetics & Stem Cells Authors: Chengwen LiShuqing WuBlake AlbrightMatthew HirschWuping LiYu-Shan TsengMavis Agbandje-McKennaScott McPheeAravind AsokanR Jude Samulski Source Type: research

More News: Genetics